BioLineRx Market Cap

BioLineRx has a market cap or net worth of 31.33 million as of April 29, 2026. Its market cap has decreased by -29.84% in one year.

Market Cap

31.33M

Enterprise Value

13.55M

Revenue

3.76M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.30

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 31.33M, an increase of 19,117.77%. That is a compound annual growth rate of 31.47%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	31.33M	-25.00%
Dec 31, 2025	41.77M	-51.17%
Dec 31, 2024	85.55M	-79.39%
Dec 31, 2023	415.08M	314.57%
Dec 29, 2022	100.12M	-67.59%
Dec 30, 2021	308.95M	60.58%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Evogene	29.63M
Clal Biotechnology Industries	52.70M
BioLight Life Sciences	21.81M
Can-Fite BioPharma	20.77M
XTL Biopharmaceuticals	18.92M
Purple Biotech	18.59M
Matricelf	68.75M
Geffen Residence & Renewal	270.51M

Market Cap Rankings